NFKBIA and head and neck squamous cell carcinoma: This effect was due to the capacity of CUR and cisplatin to decrease cyclin D1 expression and modulate the NF-κB pathway through reduction of IκBα, phospho-IκBα, and IKKβ expression in HNSCC cells.